DXN share price up after posting higher net profit
KUALA LUMPUR: DXN Holdings Bhd's share price rose in the morning trading session after it posted higher net profit for the financial year ended Feb 28, 2025 (FY2025).
At 10.09 am, the global health-oriented and wellness direct selling company's share price was half-a-sen up to 51 sen, with 2.01 million shares changing hands.
DXN Holdings' net profit for FY2025 rose to RM329.03 million compared to RM310.99 million previously while revenue increased 5.8 per cent to RM1.91 billion from RM1.80 billion previously, according to a filing with Bursa Malaysia.
In the fourth quarter (4Q) of FY2025, its net profit rose to RM84.72 million compared to RM79.02 million previously, while revenue decreased to RM458.90 million from RM470.64 million previously.
RHB Investment Bank Bhd said DXN Holdings' FY2025 results met its expectations with solid growth in key markets and efficiency gains which more than offset the impact of unfavourable foreign exchange.
"Valuation is highly attractive considering the effective business model, Brazil's expansion as a medium-term growth driver, and sturdy balance sheet to facilitate a generous dividend payout," it said in a note today.
For outlook, it said DXN's earnings growth will be supported by the relentless growth momentum in major markets.
"The core strategies of recruiting new members and enhancing their productivity levels will continue to revolve around member engagement, complemented by quality new product launches.
"Meanwhile, the recent capacity expansion should help capture the rising demand and roll out new product categories to broaden the addressable markets," it said.
On top of that, it look forward to the results of the entry to Brazil, leveraging on DXN's established existing network in the Latin American region.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
4 days ago
- The Star
More than 90 Malaysian companies make Fortune Southeast Asia 500 List
KUALA LUMPUR: A total of 92 Malaysian companies have made it onto Fortune's 2025 Southeast Asia 500 list, released recently, placing Malaysia third overall behind Indonesia and Thailand. According to Fortune, the second annual Southeast Asia 500 list highlights a region poised to capitalise on global supply chain shifts and rapid growth in industries such as mining, electric vehicles, and artificial intelligence. 'The seven countries in last year's inaugural Southeast Asia 500 list—Indonesia, Thailand, Malaysia, Singapore, Vietnam, the Philippines, and Cambodia—return in 2025 and continue to make their mark on the region's economy,' Fortune said on its website. 'Together, the Southeast Asia 500 companies are playing an increasingly important role in global supply chains—capturing manufacturing capacity shifting from China, which is drawing significant capital flows and reshaping global trade dynamics,' it added. Companies are ranked by revenues for their latest available respective fiscal years ended on or before Dec 31, 2024, unless otherwise noted. The annual list shows that Malaysian companies generated a combined US$201.6bil, with the top 10 companies accounting for over 44% of the total. Malayan Banking Bhd (Maybank) remains the only Malaysian firm in the top 20 by revenue and also ranks among the region's most profitable companies. Among the top 10 Malaysian companies on the list are Sime Darby Bhd (ranked 22nd in Southeast Asia), Tenaga Nasional Bhd (24th), CIMB Group Holdings Bhd (32nd), and PETRONAS Dagangan (34th). Others include PETRONAS Chemicals (44th), YTL (46th), Genting (53rd), Public Bank (57th), and IHH Healthcare (65th). CLICK TO ENLARGE Meanwhile, DXN Holdings debuts at 491st in the 2025 Fortune Southeast Asia ranking. 'We are honoured and delighted to be recognised by Fortune as one of Southeast Asia's top 500 companies. We started small in Kedah. This honour is a reflection of many years of dedication of everyone in DXN in the manufacturing and direct selling of wellness to our customers worldwide. 'This achievement is a testament to the resilience of our business model and the strength of our extensive member network. It reinforces the impact we are making across several jurisdictions and markets. This recognition inspires us to reach even greater heights,' DXN founder and executive chairman Datuk Lim Siow Jin said in a separate statement. Affin Group and Yinson have been named to the Fortune Southeast Asia 500 for the second consecutive year, reflecting their strong financials, sustained growth, and rising regional presence. 'Being recognised on the Fortune Southeast Asia 500 list for a second year is a meaningful milestone for Yinson. It reflects the collective efforts of our people, partners, and communities. As Southeast Asia evolves into a critical region for rapid energy transition, Yinson remains committed to advancing solutions that are innovative, inclusive, and future-focused,' Yinson Group CEO Lim Chern Yuan said.
The Sun
20-05-2025
- The Sun
Sports Toto posts higher Q3, nine-month revenue and pre-tax profit, declares 2 sen interim dividend
PETALING JAYA: Sports Toto Bhd (SPToto) reported revenue of RM1.91 billion for the third quarter ended March 31, 2025, a climb of 12.5% over revenue of RM1.69 billion in the previous year's corresponding quarter. The group registered RM147.5 million pre-tax profit, a commendable improvement of 45.7% from the pre-tax profit of RM101.2 million in the corresponding quarter of the previous year. The improved results for the quarter ended March 31, 2025 was mainly due to the strong performance of STM Lottery Sdn Bhd and improved performance of HR Owen Plc. STM Lottery's current quarter revenue was higher by 20.8% despite the number of draws that remained the same as in the corresponding quarter of the previous year (42 draws). This was primarily driven by an exceptional surge in the accumulated jackpot from the Supreme Toto 6/58 game. Aligned with the higher revenue achieved and further supported by a lower prize payout, its pre-tax profit rose by 45.8% in the current quarter, as compared to the corresponding quarter of the previous year. HR Owen's current quarter revenue raised by 14% when compared to the previous year's corresponding quarter mainly attributed to higher sales volumes in both new and used car sectors. Sales from the new marque, Lotus, which is now represented by the company contributed to the revenue increase, while the launches of certain new models also supported the improved performance in this quarter. When converted into ringgit, the revenue growth was only 6.9% due to the unfavourable foreign exchange effect. HR Owen's pre-tax profit increased to RM17.9 million from RM11.3 million in the last year same quarter which aligned with the improved revenue attained. For the nine-month period ended March 31, 2025, SPToto reported revenue of RM4.83 billion, an increase of 3.7% over the revenue of RM4.66 billion reported in the previous year's corresponding period, mainly driven by the both STM Lottery and HR Owen. Pre-tax profit saw an increase of 24.8% to RM298.5 million from RM239.1 million in the corresponding nine-month period of the previous year. STM Lottery reported revenue growth of 6%, despite fewer number of draws conducted in the current period under review (123 draws versus 126 draws in the previous year corresponding period). The growth was primarily driven by a sudden surge in ticket sales from the Supreme Toto 6/58 game when its accumulated jackpot grew exceptionally in the period. In tandem with the revenue growth coupled with lower prize payout, its pre-tax profit increased by 23.6% in the period under review. HR Owen reported an increase in revenue of 6.8% compared to the previous year's corresponding period, supported by optimistic demand from the used car sector as well as contribution from the new marque, Lotus, which is now represented by the company. However, the unfavourable foreign exchange effect resulted in a more modest revenue increase of 2.3% when converted into ringgit. It reported a lower pre-tax loss of RM1.4 million compared to a pre-tax loss of RM4.1 million in the previous year's corresponding period, mainly attributed to the revenue growth as well as lower finance cost incurred following the interest rate reduction in the UK. The board has declared a third interim dividend of 2 sen per share, amounting to about RM26.7 million for the financial year ending June 30 2025. The dividend is payable on July 18 and the entitlement date is fixed on June 30. With this, the total dividend distribution for the financial period ended March 31, 2025 is about RM80.3 million. The directors remain cautiously optimistic that the group's business will remain stable and resilient. The number forecast operation (NFO) business is expected to continue its upward trajectory of per draw sales growth driven by favourable consumer spending and continued consumer interest in the jackpot games. Further with regard to the closure of legal NFO outlets in the two northern states (Kedah and Perlis), the directors are concerned with the continued encroachment of illegal operators in these underserved areas. Despite the prevailing uncertainties and global economy headwinds including trade protectionism and the inflationary tariff impact, the directors are confident that the group will continue its lead in terms of the market share in NFO market and the group's businesses are expected to be encouraging and maintain a positive outlook for the remaining quarter of financial year ending June 30, 2025.
The Star
02-05-2025
- The Star
Dr Mah advocates for regulatory body to oversee private hospital fees
Support for regulating private hospital charges on supplies & services WE strongly support the urgent call for a regulatory body to oversee and standardise charges imposed by private hospitals for supplies and services. Alarming examples—such as RM43.35 for an ice bag or RM18.80 for baby wipes—highlight the extent of unchecked profiteering that is placing an unfair burden on patients. In another case, a private hospital in Kuala Lumpur charged a patient RM1 for a sheet of disposable garbage bag—easily available at RM1.80 for 10 sheets in convenience stores—and RM3 for a yellow plastic bag meant for used syringes. Other items, like a plastic apron supposedly worn by the operating theatre nurse, were also billed. These charges are nearly impossible for patients to challenge, as hospitals often claim such items were used during surgery when patients are unconscious under anaesthetic. Hospital supplies and services (HSS)—including consumables, diagnostic tests, and use of medical equipment—now make up as much as 70% of private hospital bills, according to Bank Negara Malaysia. While professional fees and room charges are regulated or fixed, HSS costs remain largely unchecked. This lack of oversight fuels medical inflation and drives up insurance premiums, making private healthcare increasingly unaffordable. Patients must not be treated as passive recipients of excessive bills. They have a right to clear, upfront information about all charges before treatment. Too often, they are presented with lengthy, itemised bills—without explanation or the ability to make informed choices. This erodes trust in private healthcare. We echo calls for common-sense reforms. Clear regulations must ensure that prices for consumables and services are fair, reasonable, publicly displayed and relayed to patients prior to treatment or surgery. A regulatory body—including the Health Ministry, private healthcare providers, consumer groups, and civil society—should be established to oversee and enforce these standards. Healthcare providers must also adopt cost-effective practices such as using generic medicines and evidence-based diagnostics, without compromising the quality of care. Private hospitals are essential to our health system, but they must operate with fairness, ethics, and accountability. Affordable, transparent healthcare should be a right—not a luxury—for all Malaysians. The time for action is now. The government must introduce decisive policies and take immediate action to curb profiteering and protect patients across the country. Regulation of private hospital charges is not just overdue—it is a matter of public interest and social justice. Datuk Dr Mah Hang Soon MCA Deputy President
